Publication Type : Journal Article
Publisher : Elsevier BV
Source : Bioorganic & Medicinal Chemistry Letters
Url : https://doi.org/10.1016/j.bmcl.2020.127594
Keywords : Cisplatin analogs, Dihydroquinoline, Tetrahydroquinoline, Anticancer leads, Redox chemotherapy
Campus : Kochi
School : School of Pharmacy
Department : Pharmaceutics
Year : 2020
Abstract : New cisplatin analogs in which the diamminedichloro-Pt(II) unit is conjugated to dihydroquinoline- or tetrahydroquinoline frameworks were synthesized and subjected to biological evaluation in order to understand their effects on cellular redox homeostasis and cell viability. They exhibited better selectivity towards cancer cells (A549) compared to mice fibroblast NIH3T3 cells, with cytotoxicity in the same range as that of cisplatin. There was structure-dependent variation in the levels of ROS and were also able to induce cell death, as evidenced by accumulation of cells in sub-G1 phase.
Cite this Research Publication : Sateeshkumar Kumbhakonam, Soumya Saroj, Nalini Venkatesan, Karunagaran Devarajan, Muraleedharan K. Manheri, Reactive Pt(II) center as part of redox-active quinoline-based heterocyclic scaffolds toward new anticancer leads, Bioorganic & Medicinal Chemistry Letters, Elsevier BV, 2020, https://doi.org/10.1016/j.bmcl.2020.127594